DE69327656T2 - Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthalten - Google Patents
Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthaltenInfo
- Publication number
- DE69327656T2 DE69327656T2 DE1993627656 DE69327656T DE69327656T2 DE 69327656 T2 DE69327656 T2 DE 69327656T2 DE 1993627656 DE1993627656 DE 1993627656 DE 69327656 T DE69327656 T DE 69327656T DE 69327656 T2 DE69327656 T2 DE 69327656T2
- Authority
- DE
- Germany
- Prior art keywords
- disease
- pseudorabies virus
- animal diseases
- pct
- aujesky
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000031295 Animal disease Diseases 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000035772 mutation Effects 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000009305 pseudorabies Diseases 0.000 abstract 2
- 101000686824 Enterobacteria phage N4 Virion DNA-directed RNA polymerase Proteins 0.000 abstract 1
- 101000644628 Escherichia phage Mu Tail fiber assembly protein U Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108010059485 brain synaptic membrane glycoprotein gp 50 Proteins 0.000 abstract 1
- 101150030521 gI gene Proteins 0.000 abstract 1
- 101150118312 gp63 gene Proteins 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92202096 | 1992-07-09 | ||
PCT/NL1993/000146 WO1994001573A1 (en) | 1992-07-09 | 1993-07-08 | Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69327656D1 DE69327656D1 (de) | 2000-02-24 |
DE69327656T2 true DE69327656T2 (de) | 2000-08-03 |
Family
ID=8210764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1993627656 Expired - Fee Related DE69327656T2 (de) | 1992-07-09 | 1993-07-08 | Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthalten |
Country Status (18)
Country | Link |
---|---|
US (1) | US5674500A (de) |
EP (1) | EP0654086B1 (de) |
JP (1) | JPH07509127A (de) |
KR (1) | KR100341994B1 (de) |
CN (1) | CN1124159C (de) |
AT (1) | ATE189000T1 (de) |
AU (1) | AU684252B2 (de) |
CA (1) | CA2139507C (de) |
DE (1) | DE69327656T2 (de) |
DK (1) | DK0654086T3 (de) |
ES (1) | ES2143507T3 (de) |
HU (1) | HU220099B (de) |
NZ (1) | NZ254267A (de) |
PL (1) | PL174219B1 (de) |
RU (1) | RU2158308C2 (de) |
TW (1) | TW289731B (de) |
WO (1) | WO1994001573A1 (de) |
ZA (1) | ZA934882B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE118352T1 (de) * | 1991-06-06 | 1995-03-15 | Stichting Centr Diergeneeskund | Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits. |
US6007825A (en) * | 1991-12-23 | 1999-12-28 | American Cyanamid Company | Serpulina hyodysenteriae vaccine comprising a tly gene mutant |
US7223411B1 (en) | 1992-07-31 | 2007-05-29 | Dana-Farber Cancer Institute | Herpesvirus replication defective mutants |
US6380376B1 (en) * | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6773908B1 (en) * | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
WO1994021807A2 (en) * | 1993-03-19 | 1994-09-29 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
EP0659885A1 (de) * | 1993-12-21 | 1995-06-28 | Akzo Nobel N.V. | Impstoffe gegen von Antikörper abhängende Vergrösserung (ADE) der Virus-Infektivität |
EP0693551A1 (de) * | 1994-07-18 | 1996-01-24 | Akzo Nobel N.V. | gD-Negative Rinder-Herpesvirus Mutanten, mit der Fähigkeit zur direkten Zell zu Zell Übertragung |
EP0839912A1 (de) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
US6399354B1 (en) | 1998-07-31 | 2002-06-04 | President And Fellows Of Harvard College | Replication-competent virus expressing a detectable fusion protein |
JP3961222B2 (ja) * | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Prrsvワクチン |
DK1183332T3 (da) * | 1999-04-22 | 2010-09-06 | Us Agriculture | Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142 |
CA2509494A1 (en) * | 2002-12-11 | 2004-06-24 | University Of Massachusetts | Method of introducing sirna into adipocytes |
KR20070028547A (ko) * | 2004-06-18 | 2007-03-12 | 리전츠 오브 더 유니버스티 오브 미네소타 | 바이러스에 감염되고 백신접종된 생물의 동정 |
US7632636B2 (en) * | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
CA2611820C (en) | 2005-06-24 | 2015-10-06 | Regents Of The University Of Minnesota | Prrs viruses, infectious clones, mutants thereof, and methods of use |
CN101081298A (zh) * | 2007-06-26 | 2007-12-05 | 陈少莺 | 一种猪伪狂犬病新型亚单位疫苗制备方法 |
CN102316895A (zh) * | 2008-08-25 | 2012-01-11 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 抗高致病性猪生殖与呼吸综合征(hp prrs)的疫苗 |
CN101457215B (zh) * | 2008-12-01 | 2010-11-17 | 华中农业大学 | 重组猪伪狂犬病毒-猪繁殖与呼吸综合征病毒-猪圆环病毒基因工程毒株及应用 |
AR078253A1 (es) * | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
WO2012110489A2 (en) | 2011-02-17 | 2012-08-23 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
SG192821A1 (en) | 2011-02-17 | 2013-09-30 | Boehringer Ingelheim Vetmed | Commercial scale process for production of prrsv |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US9315781B2 (en) | 2011-07-29 | 2016-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Infectious CDNA clone of european PRRS virus and uses thereof |
US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
CN104250640A (zh) * | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN111560355A (zh) * | 2015-03-20 | 2020-08-21 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3677494D1 (de) * | 1985-07-29 | 1991-03-14 | Upjohn Co | Virus-impfstoff. |
US5352575A (en) * | 1985-10-04 | 1994-10-04 | The Upjohn Company | Pseudorabies virus protein |
US4999296A (en) * | 1986-04-29 | 1991-03-12 | Novagene, Inc. | Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same |
NL8902087A (nl) * | 1989-08-17 | 1991-03-18 | Stichting Tech Wetenschapp | Niet-natuurlijk voorkomend pseudorabiesvirus en vaccins die dit bevatten. |
BR9106879A (pt) * | 1990-09-25 | 1993-07-20 | Cantab Pharma Res | Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante |
ATE288483T1 (de) * | 1992-07-30 | 2005-02-15 | Akzo Nobel Nv | Nicht-verbreitendes lebendes herpesvirusvakzin |
-
1993
- 1993-07-02 TW TW82105279A patent/TW289731B/zh active
- 1993-07-07 ZA ZA934882A patent/ZA934882B/xx unknown
- 1993-07-08 HU HU9500039A patent/HU220099B/hu not_active IP Right Cessation
- 1993-07-08 AT AT93916297T patent/ATE189000T1/de not_active IP Right Cessation
- 1993-07-08 EP EP19930916297 patent/EP0654086B1/de not_active Expired - Lifetime
- 1993-07-08 DE DE1993627656 patent/DE69327656T2/de not_active Expired - Fee Related
- 1993-07-08 PL PL93307049A patent/PL174219B1/pl not_active IP Right Cessation
- 1993-07-08 WO PCT/NL1993/000146 patent/WO1994001573A1/en active IP Right Grant
- 1993-07-08 RU RU95105518A patent/RU2158308C2/ru not_active IP Right Cessation
- 1993-07-08 CA CA 2139507 patent/CA2139507C/en not_active Expired - Fee Related
- 1993-07-08 NZ NZ254267A patent/NZ254267A/en unknown
- 1993-07-08 US US08/373,325 patent/US5674500A/en not_active Expired - Fee Related
- 1993-07-08 ES ES93916297T patent/ES2143507T3/es not_active Expired - Lifetime
- 1993-07-08 AU AU45898/93A patent/AU684252B2/en not_active Ceased
- 1993-07-08 JP JP6503188A patent/JPH07509127A/ja active Pending
- 1993-07-08 KR KR1019950700064A patent/KR100341994B1/ko not_active IP Right Cessation
- 1993-07-08 DK DK93916297T patent/DK0654086T3/da active
- 1993-07-09 CN CN93108005A patent/CN1124159C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU9500039D0 (en) | 1995-03-28 |
TW289731B (de) | 1996-11-01 |
DE69327656D1 (de) | 2000-02-24 |
KR100341994B1 (ko) | 2002-11-30 |
DK0654086T3 (da) | 2000-06-13 |
EP0654086A1 (de) | 1995-05-24 |
PL174219B1 (pl) | 1998-06-30 |
CN1086143A (zh) | 1994-05-04 |
ZA934882B (en) | 1994-02-03 |
RU95105518A (ru) | 1997-03-27 |
PL307049A1 (en) | 1995-05-02 |
CN1124159C (zh) | 2003-10-15 |
JPH07509127A (ja) | 1995-10-12 |
CA2139507C (en) | 2005-04-19 |
AU684252B2 (en) | 1997-12-11 |
EP0654086B1 (de) | 2000-01-19 |
RU2158308C2 (ru) | 2000-10-27 |
HU220099B (hu) | 2001-10-28 |
AU4589893A (en) | 1994-01-31 |
ATE189000T1 (de) | 2000-02-15 |
ES2143507T3 (es) | 2000-05-16 |
HUT70986A (en) | 1995-11-28 |
US5674500A (en) | 1997-10-07 |
WO1994001573A1 (en) | 1994-01-20 |
CA2139507A1 (en) | 1994-01-20 |
NZ254267A (en) | 1996-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69327656D1 (de) | Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthalten | |
DE69625802D1 (de) | Impfstoffe gegen die pest | |
Scott et al. | IL-12 as an adjuvant for cell-mediated immunity | |
ATE233101T1 (de) | Polynukleotide vakzine gegen den papilloma virus | |
Rotman et al. | IL‐12 eliminates the Th‐2 dependent protective immune response of mice to larval Strongyloides stercoralis | |
Vanloubbeeck et al. | The immunology of Leishmania infection and the implications for vaccine development | |
Gierynska et al. | Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes | |
PH25776A (en) | Pseudorabies virus mutants incapable of producing glycoprotein x | |
SE9003198D0 (sv) | Fish vaccine comprising a virulent, invasive bacterium | |
Rosado-Vallado et al. | Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana | |
DE69333751D1 (de) | Nicht-verbreitendes lebendes herpesvirusvakzin | |
Vanrompay et al. | Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon‐γ on genetic immunization | |
EP0596959A4 (de) | System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung. | |
DE10399019I2 (de) | Gefl}gelkrankheit verursachende neue Bakterie und daraus stammender Impfstoff. | |
DE69131319T2 (de) | Isoliertes PCTD Plasmid aus Chlamydia trachomatis von Serotyp D, dessen Genen und davon kodierten Proteine, rekombinante Plasmide für die Expression von deren Genen als Fusionsproteine in einem keterologen System, und ihre Verwendung als Impfstoff- und/oder Diagnostiekformulierung | |
EA200301125A1 (ru) | Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы | |
Lang et al. | Serological response in sheep vaccinated against Coxiella burnetii (Q fever). | |
ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
SE9401596D0 (sv) | New compounds | |
Knopf et al. | Interleukin-12 as an Adjuvant for an | |
Epstein | The Vaccine Control of Virus-Induced Cancers | |
UA52796C2 (uk) | Вакцина абацилярна антракол проти сибірки тварин |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |